Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Author:

Basch Ethan1,Dueck Amylou C.2,Rogak Lauren J.3,Minasian Lori M.4,Kelly William Kevin5,O’Mara Ann M.6,Denicoff Andrea M.6,Seisler Drew7,Atherton Pamela J.7,Paskett Electra8,Carey Lisa9,Dickler Maura10,Heist Rebecca S.11,Himelstein Andrew12,Rugo Hope S.13,Sikov William M.14,Socinski Mark A.15,Venook Alan P.13,Weckstein Douglas J.16,Lake Diana E.10,Biggs David D.12,Freedman Rachel A.17,Kuzma Charles18,Kirshner Jeffrey J.19,Schrag Deborah20

Affiliation:

1. Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

2. Alliance Statistics and Data Center, Division of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona

3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

4. Division of Cancer Prevention, National Cancer Institute (NCI), Rockville, Maryland

5. Department of Medical Oncology and Urology, Division of Solid Tumor, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania6Clinical Research and Prostate Cancer Program, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania

6. Division of Cancer Treatment and Diagnosis, NCI, Rockville, Maryland

7. Alliance Statistics and Data Center, Division of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

8. Division of Cancer Prevention and Control, Department of Internal Medicine, Division of Epidemiology, College of Public Health, The Ohio State University, Columbus

9. Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

10. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

11. Department of Thoracic Oncology, Harvard Medical School, Massachusetts General Hospital, Boston

12. Delaware/Christiana Care NCI Community Oncology Research Program (NCORP), Helen F. Graham Cancer Center & Research Institute, Newark

13. Department of Medicine, University of California at San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco

14. Program in Women’s Oncology, Department of Obstetrics & Gynecology, Women and Infants Hospital of Rhode Island, Providence15Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island

15. Thoracic Oncology Program, Florida Hospital Cancer Institute, Orlando

16. New Hampshire Oncology Hematology, Hooksett

17. Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts

18. Southeast Clinical Oncology Research Consortium, Winston-Salem, North Carolina

19. Hematology Oncology Associates of Central New York, East Syracuse

20. Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3